RecallRadar

FDA Device recall Z-2043-2023

Access Hybritech p2PSA reagent, REF B03704 and REF A49752

On 2023-07-05 the FDA classified a Class II recall of Access Hybritech p2PSA reagent, REF B03704 and REF A49752 by Beckman Coulter, citing reagent lot numbers include an insufficient concentration of blocking reagent.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2043-2023
ClassificationClass II
Statusongoing
Initiated2023-05-17
Published2023-07-05
Last updated2026-09-13 11:56 UTC
CompanyBeckman Coulter
DistributionCA, CO, CT, FL, GA, IL, IN, MA, MI, NC, NE, NJ, NY, OH, SC, TN, TX, UT, WA

Product

Access Hybritech p2PSA reagent, REF B03704 and REF A49752.

Reason

Reagent lot numbers include an insufficient concentration of blocking reagent.

Identifiers

code_info
Lot #234320, exp. 7/31/2023, UDI (01)15099590211325(17)230731(11)220731(10)234320; Lot #234134, exp. 6/30/2023, UDI (0…Lot #234320, exp. 7/31/2023, UDI (01)15099590211325(17)230731(11)220731(10)234320; Lot #234134, exp. 6/30/2023, UDI (01)15099590211325(17)230630(11)220630(10)234134; and Lot #234133, exp. 6/30/2023, UDI (01)15099590204112(17)230630(11)220630(10)234133.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2043-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.